AI assistant
NEXALIS THERAPEUTICS LTD — Major Shareholding Notification 2021
Oct 12, 2021
65462_rns_2021-10-12_70e49aca-5af4-4514-b941-0ac4073eaa25.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
604 Page 1 of 3 15 July 2001
Form 604
Corporations Act 2001 Section 671B
Notice of change of interests of substantial holder
To Company Name/Scheme
InhaleRx Limited
ACN/ARSN
611 845 820
1. Details of substantial holder (1)
Name
Cannvalate Pty LtdACN/ARSN (if applicable)
625 982 756
There was a change in the interests of the substantial holder on Multiple dates / / The previous notice was given to the company on 08 / 01 / 2021 The previous notice was dated 08 / 01 / 2021
2. Previous and present voting power
The total number of votes attached to all the voting shares in the company or voting interests in the scheme that the substantial holder or an associate (2) had a relevant interest (3) in when last required, and when now required, to give a substantial holding notice to the company or scheme, are as follows:
| Class of securities (4) | Previous notice | Previous notice | Present notice | Present notice |
|---|---|---|---|---|
| Person’s votes | Voting power(5) | Person’s votes | Voting power(5) | |
Ordinary Fully PaidShares (ORD) |
30,189,622 |
19.21% |
33,524,924 |
19.90% |
3. Changes in relevant interests
Particulars of each change in, or change in the nature of, a relevant interest of the substantial holder or an associate in voting securities of the company or scheme, since the substantial holder was last required to give a substantial holding notice to the company or scheme are as follows:
| Date of change |
Person whose relevant interest changed |
Nature of change (6) | Consideration given in relation to change (7) |
Class and number of securities affected |
Person's votes affected |
|---|---|---|---|---|---|
ReferAnnexure1 |
|||||
4. Present relevant interests
Particulars of each relevant interest of the substantial holder in voting securities after the change are as follows:
| Holder of relevant interest |
Registered holder of securities |
Person entitled to be registered as holder (8) |
Nature of relevant interest (6) |
Class and number of securities |
Person's votes |
|---|---|---|---|---|---|
CannvalatePty Ltd |
CannvalatePty Ltd |
Cannvalate PtyLtd |
Direct |
33,524,924ORD |
33,524,924 |
604 Page 2 of 3 15 July 2001
5. Changes in association
The persons who have become associates (2) of, ceased to be associates of, or have changed the nature of their association (9) with, the substantial holder in relation to voting interests in the company or scheme are as follows:
| Name and ACN/ARSN (if applicable) | Nature of association |
|---|---|
N/A |
N/A |
6. Addresses
The addresses of persons named in this form are as follows:
| Name | Address |
|---|---|
Cannvalate Pty Ltd |
14/456 St Kilda Road, Melbourne VIC 3004 |
Signature
| print name sign here |
Darryl Daviescapacity Director |
|---|---|
date12/10/2021 |
|
DIRECTIONS
-
(1 If there are a number of substantial holders with similar or related relevant interests (eg. a corporation and its related corporations, or the ) manager and trustee of an equity trust), the names could be included in an annexure to the form. If the relevant interests of a group of persons are essentially similar, they may be referred to throughout the form as a specifically named group if the membership of each group, with the names and addresses of members is clearly set out in paragraph 6 of the form.
-
(2 See the definition of "associate" in section 9 of the Corporations Act 2001.
-
)
-
(3 See the definition of "relevant interest" in sections 608 and 671B(7) of the Corporations Act 2001.
-
)
-
(4 The voting shares of a company constitute one class unless divided into separate classes.
)
- (5 The person's votes divided by the total votes in the body corporate or scheme multiplied by 100.
)
-
(6 Include details of:
-
)
-
(a) any relevant agreement or other circumstances because of which the change in relevant interest occurred. If subsection 671B(4) applies, a copy of any document setting out the terms of any relevant agreement, and a statement by the person giving full and accurate details of any contract, scheme or arrangement, must accompany this form, together with a written statement certifying this contract, scheme or arrangement; and
-
(b) any qualification of the power of a person to exercise, control the exercise of, or influence the exercise of, the voting powers or disposal of the securities to which the relevant interest relates (indicating clearly the particular securities to which the qualification applies).
See the definition of "relevant agreement" in section 9 of the Corporations Act 2001.
- (7 Details of the consideration must include any and all benefits, money and other, that any person from whom a relevant interest was acquired ) has, or may, become entitled to receive in relation to that acquisition. Details must be included even if the benefit is conditional on the happening or not of a contingency. Details must be included of any benefit paid on behalf of the substantial holder or its associate in relation to the acquisitions, even if they are not paid directly to the person from whom the relevant interest was acquired.
Annexure 1 – FORM 604
InhaleRx Limited
ACN 611 845 820
| Date of change |
Person whose relevant interest changed |
Nature of change (6) | Consideration given in relation to change (7) |
Class and number of securities |
Person’s votes affected |
|---|---|---|---|---|---|
| 11/10/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.105 per share |
305,248 ORD |
305,248 |
| 23/8/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.095 per share |
290,036 ORD |
290,036 |
| 23/8/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.096 per share |
300,000 ORD |
300,000 |
| 23/8/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.095 per share |
9,964 ORD |
9,964 |
| 12/8/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.10 per share | 100,000 ORD |
100,000 |
| 12/8/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.099874 per share |
50,000 ORD |
50,000 |
| 11/8/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.10 per share | 275,000 ORD |
275,000 |
| 23/7/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.11 per share | 498,000 ORD |
498,000 |
| 21/7/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.11 per share | 509,000 ORD |
509,000 |
| 20/7/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.115 per share |
600,000 ORD |
600,000 |
| 31/3/21 | Cannvalate Pty Ltd |
Shares sold on market |
$0.12 per share | (91,583) ORD |
(91,583) |
| 17/3/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.12 per share | 187,000 ORD |
187,000 |
| 12/3/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.12 per share | 257,000 ORD |
257,000 |
| 12/3/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.12 per share | 24,209 ORD |
24,209 |
| 20/1/21 | Cannvalate Pty Ltd |
Shares purchased on market |
$0.14 per share | 21,428 ORD |
21,428 |